Gonadotropin-releasing hormone (GnRH) deficiency under treatment: psychological and sexual functioning impacts

Hormones : International Journal of Endocrinology and Metabolism
Neoklis A GeorgopoulosKonstantinos Assimakopoulos

Abstract

GnRH (gonadotropin releasing hormone) is a crucial hormone for sexual development, puberty, and fertility, and its deficiency leads to hypogonadotropic hypogonadism (HH), which causes abnormal secondary sexual development and infertility. The combination of the lack of sense of smell, i.e., anosmia, and HH is a type of GnRH deficiency known as Kallmann syndrome, which affects both men and women. The impact of Kallmann syndrome can be very severe and causes a variety of psychological problems in patients. The aim of the present study was to investigate psychopathology, sexuality, and personality characteristics in patients with GnRH deficiency under hormonal replacement therapy. A total of 38 patients with GnRH deficiency aged 30.6 ± 10.44 years and 38 healthy matched for age individuals participated in the study and completed a series of questionnaires concerning sexual functioning, ego defense mechanisms, quality of life, personality characteristics, as well as anxiety and depression. After adjustment for anxiety and depression, no difference in sexuality parameters were reported between men with and without GnRH deficiency, while women with GnRH deficiency had significantly lower sexual desire compared to controls. Concerning...Continue Reading

References

Jan 16, 1992·The New England Journal of Medicine·J WeissJ L Jameson
Feb 1, 1989·Neurology·J D SchwankhausR J Sherins
Jun 1, 1983·Acta Psychiatrica Scandinavica·A S Zigmond, R P Snaith
Jan 1, 1993·Psychoneuroendocrinology·M A CowenD N Bertollo
Mar 1, 1993·The Journal of Steroid Biochemistry and Molecular Biology·C E Roselli, J A Resko
Feb 9, 2000·Archives of General Psychiatry·A TuitenR Verbaten
Oct 1, 1953·Journal of Consulting Psychology·F BARRON
Sep 23, 2003·Menopause : the Journal of the North American Menopause Society·Rebecca GoldstatSusan R Davis
Feb 25, 2005·The Journal of Clinical Endocrinology and Metabolism·Melvin M Grumbach
Apr 14, 2005·International Journal of Psychiatry in Medicine·George A VagenakisNeoklis A Georgopoulos
Feb 8, 2007·The Journal of Clinical Endocrinology and Metabolism·K K MillerA Klibanski
Jan 9, 2008·Experimental and Clinical Psychopharmacology·Gen KanayamaHarrison G Pope
Mar 8, 2008·Annals of General Psychiatry·Ioannis MichopoulosLefteris Lykouras
Mar 21, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Peter J SchmidtDavid R Rubinow
Sep 5, 2008·AJNR. American Journal of Neuroradiology·M Koenigkam-SantosM Castro
Jul 25, 2009·Journal of Psychiatric Practice·Fahd Aziz ZarroufMartin Kommor
Jun 23, 2010·Psychological Bulletin·Martin S HaggerNikos L D Chatzisarantis
Jul 8, 2010·Neuroendocrinology·Ravikumar BalasubramanianWilliam F Crowley
Sep 16, 2010·Annals of the New York Academy of Sciences·Alessandra Graziottin
Dec 16, 2010·Menopause International·Rossella E NappiFranco Polatti
Jul 30, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Amy TurriffBarbara Biesecker
Aug 21, 2012·Journal of Psychiatric Research·Hilary Weingarden, Keith D Renshaw
Jan 19, 2013·BMJ Case Reports·Willem M A VerhoevenLies Hoefsloot
Mar 26, 2014·The American Journal of Clinical Hypnosis·Claire Frederick
Jan 1, 2015·Journal of Applied Developmental Psychology·Seth J SchwartzLarry F Forthun

❮ Previous
Next ❯

Citations

Jul 3, 2021·Journal of Clinical Medicine·Małgorzata KałużnaMarek Ruchała

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.